Steroid showdown: which eye treatment wins for rare VKH disease?
NCT ID NCT07405489
First seen Feb 14, 2026 · Last updated Apr 29, 2026 · Updated 9 times
Summary
This study looked at 30 people with VKH disease, a rare condition that causes eye inflammation and can lead to vision loss. Researchers compared two steroid treatments: oral prednisolone (pills) and an injection behind the eye (posterior sub-Tenon triamcinolone acetonide). The goal was to see which better controls inflammation and improves vision over 3 to 6 months, while also checking for side effects and recurrence.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VKH SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Benha University
Banhā, Benha, 13111, Egypt
Conditions
Explore the condition pages connected to this study.